3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 3
2
Phase 1
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Stomach Neoplasms
23
Colorectal Neoplasms
4
Biliary Tract Neoplasms
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancoast Syndrome
1
Neoplasms
1
Locally Advanced Gastric or Gastroesophageal Junction Cancer
1
Locally Advanced Gastric Adenocarcinoma
1
Klatskin Tumor
1
Hand-Foot Syndrome
1
Gastric Adenocarcinoma
1
Gallbladder Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Bile Duct Neoplasms
1
Advanced Gastric Cancer
1
Adenocarcinoma
1
Interventions
Leucovorin
22
Fluorouracil
22
Paclitaxel
21
Gemcitabine
21
Docetaxel
21
Capecitabine
21
Irinotecan
16
Carboplatin
15
Radiosurgery
14
Oxaliplatin
13
Cisplatin
13
Bevacizumab
13
Zoledronic Acid
12
pembrolizumab
11
Radiotherapy
11
Fulvestrant
11
palbociclib
9
Pemetrexed
9
Drug Therapy
9
130-nm albumin-bound paclitaxel
9
Surgical Procedures, Operative
7
Letrozole
7
Ibandronic Acid
7
abemaciclib
6
Trastuzumab
6
Prednisone
6
Vinorelbine
5
Folfox protocol
5
Floxuridine
5
Doxorubicin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasm Metastasis
×
S 1 (combination)
×
Clear all
NCT01918852
2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3
Completed
161 enrolled
NCT00602745
2016-05-26
S-1 Pancreas
Sanofi
Phase 3
Terminated
61 enrolled